At one time, a factory in Denmark run by pharmaceutical firm Novo Nordisk A/S (ADR: NVO) made half of the world’s supply of insulin. Vowing to never run short of a product that people’s lives depended upon, Novo kept a five-year supply in the deep freeze.
Few companies will go to such lengths to maintain optimal inventory levels. However, the anecdote is instructional, especially in light of recent events: While there’s a price to be paid for building resilience into supply chains, there is an...
https://www.freightwaves.com/news/what-price-will-the-supply-chain-pay-for-resiliency